×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Cardiac Rehabilitation Devices Market

ID: MRFR/MED/12091-HCR
100 Pages
Garvit Vyas
October 2025

US Cardiac Rehabilitation Devices Market Research Report By Device Type (Elliptical Trainer, Rower, Blood Pressure Monitor, Treadmill, Stabilization Ball, Heart Rate Monitor), By End User (Rehab Centers, Research Centers, Specialty Centers, Hospitals, Clinics), By Patient Type (Percutaneous Coronary Intervention, Myocardial Ischemia, Coronary Artery Bypass Grafting, Coronary Artery Disease) and By Phase (Phase I, Phase II, Phase III) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Cardiac Rehabilitation Devices Market Infographic
Purchase Options

US Cardiac Rehabilitation Devices Market Summary

As per MRFR analysis, the US cardiac rehabilitation-devices market size was estimated at 362.6 USD Million in 2024. The US cardiac rehabilitation-devices market is projected to grow from 381.02 USD Million in 2025 to 625.52 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.08% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The US cardiac rehabilitation-devices market is poised for growth driven by technological advancements and increasing patient-centered care initiatives.

  • Technological advancements in cardiac rehabilitation devices are enhancing patient outcomes and engagement.
  • Regulatory support is fostering innovation and streamlining the approval process for new devices.
  • The focus on patient-centered care is reshaping rehabilitation protocols to better meet individual needs.
  • The increasing prevalence of cardiovascular diseases and growing awareness of rehabilitation benefits are key drivers of market expansion.

Market Size & Forecast

2024 Market Size 362.6 (USD Million)
2035 Market Size 625.52 (USD Million)

Major Players

Medtronic (US), Boston Scientific (US), Philips (NL), Abbott (US), Bayer (DE), GE Healthcare (US), Johnson & Johnson (US), Siemens Healthineers (DE), Cardinal Health (US)

US Cardiac Rehabilitation Devices Market Trends

The cardiac rehabilitation-devices market is currently experiencing notable growth. This growth is driven by an increasing prevalence of cardiovascular diseases and a rising awareness of the importance of rehabilitation post-cardiac events. This market encompasses a variety of devices designed to assist patients in their recovery, including monitoring systems, exercise equipment, and telehealth solutions. The integration of advanced technologies, such as wearable devices and mobile applications, appears to enhance patient engagement and adherence to rehabilitation programs. Furthermore, the emphasis on personalized care and remote monitoring solutions suggests a shift towards more patient-centered approaches in cardiac rehabilitation. In addition, the regulatory landscape is evolving, with government initiatives aimed at improving access to rehabilitation services. This may lead to increased adoption of cardiac rehabilitation-devices, as healthcare providers seek to comply with new standards and guidelines. The market's trajectory indicates a potential for innovation, particularly in the development of devices that cater to diverse patient needs. As healthcare systems continue to adapt, the cardiac rehabilitation-devices market is likely to expand, offering new opportunities for manufacturers and healthcare providers alike.

Technological Advancements

The cardiac rehabilitation-devices market is witnessing rapid technological advancements, particularly in the realm of telehealth and remote monitoring. These innovations facilitate real-time data collection and patient feedback, which may enhance the effectiveness of rehabilitation programs. Wearable devices and mobile applications are becoming increasingly prevalent, allowing patients to track their progress and engage more actively in their recovery.

Regulatory Support

Regulatory support is playing a crucial role in shaping the cardiac rehabilitation-devices market. Government initiatives aimed at promoting cardiovascular health and improving access to rehabilitation services are likely to drive demand for these devices. As healthcare policies evolve, manufacturers may find new opportunities to align their products with regulatory requirements, thereby enhancing market penetration.

Focus on Patient-Centered Care

There is a growing emphasis on patient-centered care within the cardiac rehabilitation-devices market. This trend reflects a broader shift towards personalized treatment plans that cater to individual patient needs. By prioritizing patient engagement and satisfaction, healthcare providers may improve outcomes and foster long-term adherence to rehabilitation programs.

US Cardiac Rehabilitation Devices Market Drivers

Government Initiatives and Funding

Government initiatives aimed at improving cardiovascular health are significantly influencing the cardiac rehabilitation-devices market. Programs designed to promote awareness and access to rehabilitation services are gaining traction, with federal and state funding allocated to support these efforts. For instance, the Centers for Medicare & Medicaid Services (CMS) has expanded coverage for cardiac rehabilitation services, which is expected to increase patient participation. This financial backing not only encourages healthcare providers to invest in advanced rehabilitation devices but also enhances accessibility for patients. As a result, the cardiac rehabilitation-devices market is poised for growth, with projections indicating a potential increase in market size as more patients are referred to rehabilitation programs.

Aging Population and Increased Healthcare Needs

The aging population in the US is a significant driver of the cardiac rehabilitation-devices market. As individuals age, the risk of developing cardiovascular diseases escalates, leading to a higher demand for rehabilitation services. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, resulting in a substantial increase in the elderly population. This demographic shift is likely to create a greater need for cardiac rehabilitation, as older adults often require specialized care to recover from heart-related events. Consequently, the cardiac rehabilitation-devices market is expected to grow, as healthcare providers seek to equip themselves with the necessary devices to cater to this expanding patient population.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases in the US is a primary driver for the cardiac rehabilitation-devices market. According to the American Heart Association, cardiovascular diseases account for approximately 697,000 deaths annually, representing about 1 in every 5 deaths. This alarming statistic underscores the urgent need for effective rehabilitation solutions. As healthcare providers increasingly recognize the importance of rehabilitation in improving patient outcomes, the demand for specialized devices is expected to grow. The cardiac rehabilitation-devices market is projected to expand as more patients seek rehabilitation services post-heart events, leading to a potential increase in market value. Furthermore, the integration of these devices into standard care protocols may enhance recovery rates, thereby driving further adoption and innovation in the market.

Technological Innovations in Rehabilitation Devices

Technological advancements play a crucial role in shaping the cardiac rehabilitation-devices market. Innovations such as wearable devices, telehealth solutions, and mobile applications are transforming how rehabilitation is delivered. These technologies enable real-time monitoring of patients' progress, allowing healthcare providers to tailor rehabilitation programs to individual needs. The market is witnessing a surge in demand for devices that incorporate artificial intelligence and machine learning to enhance patient engagement and adherence. As a result, the cardiac rehabilitation-devices market is likely to experience significant growth, with estimates suggesting a compound annual growth rate (CAGR) of around 8% over the next few years. This trend indicates a shift towards more personalized and efficient rehabilitation solutions, ultimately improving patient outcomes.

Growing Awareness of Cardiac Rehabilitation Benefits

There is a growing awareness among patients and healthcare professionals regarding the benefits of cardiac rehabilitation, which is driving the cardiac rehabilitation-devices market. Educational campaigns and outreach programs have highlighted the positive impact of rehabilitation on recovery and long-term health outcomes. Studies indicate that participation in cardiac rehabilitation can reduce mortality rates by up to 30% and improve quality of life. This heightened awareness is likely to lead to increased referrals to rehabilitation programs, subsequently boosting the demand for specialized devices. As healthcare systems prioritize preventive care and chronic disease management, the cardiac rehabilitation-devices market is expected to expand, reflecting the increasing recognition of rehabilitation's role in comprehensive cardiovascular care.

Market Segment Insights

By Device Type: Treadmill (Largest) vs. Blood Pressure Monitor (Fastest-Growing)

In the US cardiac rehabilitation-devices market, the segment distribution shows a clear leadership by Treadmills, which dominate the market due to their wide acceptance and effectiveness in rehabilitation programs. Following Treadmills, Blood Pressure Monitors are gaining traction, driven by the increasing emphasis on remote health monitoring. Other devices like Elliptical Trainers and Rowers remain significant, yet they do not match the prominence of these two devices in terms of market share. Growth trends in this segment are largely influenced by the rising awareness of heart health and the aging population, which drives demand for effective cardiac rehabilitation solutions. Treadmills maintain a steady growth trajectory, while Blood Pressure Monitors are positioned as the fastest-growing segment due to technological advancements that allow for easier monitoring. The shift towards home-based rehabilitation is also propelling growth in these devices, ensuring their relevance in both clinical and home healthcare settings.

Treadmill (Dominant) vs. Blood Pressure Monitor (Emerging)

Treadmills are the dominant device in the cardiac rehabilitation segment, providing versatile workout options that are favored by users for their effectiveness in building cardiovascular endurance. These machines are often equipped with advanced features such as heart rate monitors and customizable workout plans, increasing their utility in rehabilitation settings. In contrast, Blood Pressure Monitors represent the emerging trend, becoming increasingly vital as patients seek more accessible ways to track their health metrics. Their growth is fueled by rising healthcare requests for at-home monitoring solutions, enhancing patient engagement while allowing healthcare providers to maintain oversight. Both segments cater to the core needs of cardiac patients, emphasizing safety, effectiveness, and the convenience of continuous health monitoring.

By End User: Hospitals (Largest) vs. Rehab Centers (Fastest-Growing)

In the US cardiac rehabilitation-devices market, hospitals hold the largest share, capitalizing on their comprehensive infrastructure and access to advanced medical technologies. Following closely are rehab centers, which are witnessing significant growth as they cater specifically to patients recovering from cardiac events, thereby addressing the needs of a growing population focused on rehabilitation services. Growth in the segment is driven by an aging population, rising awareness about cardiac health, and increased prevalence of heart disease. Additionally, innovative rehabilitation technologies and personalized care strategies are expected to enhance the demand in clinics and specialty centers. As hospitals continue to integrate rehabilitation into cardiac care, rehab centers are poised to expand rapidly, tapping into this evolving market landscape.

Hospitals: Dominant vs. Rehab Centers: Emerging

Hospitals are a dominant force in the market due to their extensive resources, highly trained personnel, and ability to offer a wide range of cardiac rehabilitation services. They often serve as referral centers, helping manage complex patient needs effectively. Conversely, rehab centers are emerging as a vital segment in the landscape, focusing on personalized care and tailored rehabilitation programs, which cater specifically to patients post-cardiac events. They are becoming increasingly popular for their targeted services and lower overhead costs. With the growing focus on recovery and long-term health management, both hospitals and rehab centers are adapting their approaches to meet the demand for specialized and effective rehabilitation solutions.

By Patient Type: Coronary Artery Disease (Largest) vs. Myocardial Ischemia (Fastest-Growing)

In the US cardiac rehabilitation-devices market, the patient type segment reveals a significant distribution in market share. Coronary Artery Disease holds the largest share among patient types, driven by its prevalence and the need for effective rehabilitation solutions. On the other hand, the other segments, including Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting, also maintain notable shares but do not match the dominance seen with Coronary Artery Disease. Growth trends indicate that Myocardial Ischemia is emerging as the fastest-growing segment within the patient types. Factors such as an aging population, increasing awareness of cardiac health, and advancements in rehabilitation technologies are propelling the growth of this segment. Additionally, greater emphasis on preventive care and early intervention strategies is contributing to the rising demand for devices tailored to diverse patient needs.

Coronary Artery Disease (Dominant) vs. Myocardial Ischemia (Emerging)

Coronary Artery Disease, as the dominant patient type, plays a critical role in the US cardiac rehabilitation-devices market due to its high incidence and the focus on rehabilitation to enhance recovery outcomes. Devices focused on this segment are well-established, featuring advanced monitoring and support systems that cater to extensive patient requirements. Myocardial Ischemia, labeled as an emerging segment, is quickly gaining attention as more patients are diagnosed with this condition. The market for devices aimed at this segment is characterized by innovation and increased investment in technologies that provide tailored rehabilitation solutions, thus improving patient engagement and compliance.

By Phase: Phase II (Largest) vs. Phase I (Fastest-Growing)

The market share distribution among the various phases of cardiac rehabilitation devices indicates that Phase II holds the largest portion, capitalizing on the demand for structured rehabilitation programs after hospital discharge. In contrast, Phase I, although smaller in market share, is witnessing significant growth as healthcare providers increasingly recognize the importance of early intervention in patient recovery and rehabilitation efforts. Growth trends in the segment reflect a broader understanding of cardiac health management, where Phase II is propelled by established protocols and insurer support. Meanwhile, Phase I is rapidly emerging, driven by innovative device offerings and enhanced patient education, resulting in a greater emphasis on initial rehabilitation after acute cardiac events, leading to its fastest growth trajectory in the market.

Phase II (Dominant) vs. Phase I (Emerging)

Phase II serves as the dominant player in cardiac rehabilitation devices, characterized by comprehensive programs that facilitate recovery post-hospitalization. It is essential for patient transitioning from acute care to ongoing rehabilitation, providing structured assessments and interventions tailored to individual needs. In contrast, Phase I is rapidly emerging, focusing on the critical early stage of recovery immediately after a cardiac event. Its growth is fueled by increasing awareness of the benefits of intensive monitoring and support during this crucial phase, enabling patients to optimize their recovery pathway. Both phases play integral roles, but their differing approaches reflect unique strategies to meet the evolving demands of cardiac care.

Get more detailed insights about US Cardiac Rehabilitation Devices Market

Key Players and Competitive Insights

The cardiac rehabilitation-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing emphasis on patient-centered care. Key players such as Medtronic (US), Boston Scientific (US), and Abbott (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Medtronic (US) focuses on integrating digital health solutions into its rehabilitation devices, aiming to improve patient engagement and outcomes. Meanwhile, Boston Scientific (US) emphasizes a robust pipeline of new products, particularly in wearable technology, which aligns with the growing trend of remote patient monitoring. Abbott (US) is also investing heavily in digital transformation, seeking to expand its portfolio of cardiac rehabilitation solutions through strategic acquisitions and collaborations.

The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like GE Healthcare (US) and Johnson & Johnson (US) contributes to a competitive environment where innovation and strategic partnerships are paramount.

In October 2025, Medtronic (US) announced a partnership with a leading telehealth provider to enhance its cardiac rehabilitation offerings. This collaboration is expected to facilitate remote monitoring and personalized care plans, thereby improving patient adherence to rehabilitation protocols. Such strategic moves indicate a shift towards integrated care models that prioritize patient engagement and outcomes.

In September 2025, Boston Scientific (US) launched a new wearable device designed to monitor cardiac health in real-time. This product aims to empower patients by providing them with actionable insights into their health status. The introduction of this device not only strengthens Boston Scientific's product portfolio but also positions the company as a leader in the growing market for digital health solutions.

In August 2025, Abbott (US) completed the acquisition of a digital health startup specializing in AI-driven analytics for cardiac rehabilitation. This acquisition is likely to enhance Abbott's capabilities in delivering personalized rehabilitation programs, thereby addressing the increasing demand for tailored patient care. The integration of AI into rehabilitation devices may significantly improve patient outcomes and operational efficiencies.

As of November 2025, current competitive trends in the cardiac rehabilitation-devices market include a pronounced focus on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition towards a focus on technological innovation, enhanced patient experiences, and supply chain reliability. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge.

Key Companies in the US Cardiac Rehabilitation Devices Market market include

Industry Developments

The US Cardiac Rehabilitation Devices Market has seen notable developments recently. In September 2023, Medtronic announced the launch of its new cardiac monitor, designed to enhance patient engagement in rehabilitation programs, leveraging advanced connectivity features. This innovation aligns with the growing trend towards remote monitoring solutions in cardiac care.

Additionally, in August 2023, Boston Scientific reported on the positive outcomes of their new implantable cardioverter-defibrillator technology which is expected to improve patient rehabilitation statistics significantly. On the merger and acquisition front, in July 2023, Abbott Laboratories acquired a key asset from Cardiac Science, enhancing their product portfolio in cardiac monitoring devices.

The increased funding in the cardiac rehabilitation sector indicates a robust market valuation growth, with Cleveland Clinic Innovations forming a new partnership with Inspire Medical Systems to develop next-generation rehabilitation strategies. The emphasis on research and development aims to tailor devices that match the needs of a growing patient population in the United States, especially given the prevalence of heart disease.

Regulatory bodies continue to support innovation, ensuring that advancements meet safety and efficacy standards while expanding patient access to essential rehabilitation technologies.

Future Outlook

US Cardiac Rehabilitation Devices Market Future Outlook

The cardiac rehabilitation-devices market is projected to grow at a 5.08% CAGR from 2024 to 2035, driven by technological advancements, an increasing prevalence of cardiovascular diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of telehealth platforms for remote patient monitoring
  • Integration of AI-driven analytics for personalized rehabilitation programs
  • Expansion of partnerships with healthcare providers for bundled service offerings

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic collaborations.

Market Segmentation

US Cardiac Rehabilitation Devices Market Phase Outlook

  • Phase I
  • Phase II
  • Phase III

US Cardiac Rehabilitation Devices Market End User Outlook

  • Rehab Centers
  • Research Centers
  • Specialty Centers
  • Hospitals
  • Clinics

US Cardiac Rehabilitation Devices Market Device Type Outlook

  • Elliptical Trainer
  • Rower
  • Blood Pressure Monitor
  • Treadmill
  • Stabilization Ball
  • Heart Rate Monitor

US Cardiac Rehabilitation Devices Market Patient Type Outlook

  • Percutaneous Coronary Intervention
  • Myocardial Ischemia
  • Coronary Artery Bypass Grafting
  • Coronary Artery Disease

Report Scope

MARKET SIZE 2024 362.6(USD Million)
MARKET SIZE 2025 381.02(USD Million)
MARKET SIZE 2035 625.52(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.08% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Medtronic (US), Boston Scientific (US), Philips (NL), Abbott (US), Bayer (DE), GE Healthcare (US), Johnson & Johnson (US), Siemens Healthineers (DE), Cardinal Health (US)
Segments Covered Device Type, End User, Patient Type, Phase
Key Market Opportunities Integration of telehealth solutions enhances accessibility in the cardiac rehabilitation-devices market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation in the cardiac rehabilitation-devices market.
Countries Covered US

Leave a Comment

FAQs

What is the projected market size of the US Cardiac Rehabilitation Devices Market in 2024?

The US Cardiac Rehabilitation Devices Market is expected to be valued at 310.8 million USD in 2024.

What will be the market size of the US Cardiac Rehabilitation Devices Market by 2035?

By 2035, the market is projected to reach 650.0 million USD.

What is the expected CAGR for the US Cardiac Rehabilitation Devices Market from 2025 to 2035?

The expected compound annual growth rate for the market is 6.938% from 2025 to 2035.

Who are the key players in the US Cardiac Rehabilitation Devices Market?

Major players in the market include Inspire Medical Systems, Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson.

Which device type has the largest market share in 2024?

In 2024, the Treadmill device type holds the largest market share at 100.0 million USD.

What is the market size for Elliptical Trainers in 2035?

The market size for Elliptical Trainers is anticipated to reach 170.0 million USD by 2035.

How fast is the Blood Pressure Monitor segment expected to grow?

The Blood Pressure Monitor segment is expected to grow from 60.0 million USD in 2024 to 130.0 million USD by 2035.

What challenges might impact the growth of the US Cardiac Rehabilitation Devices Market?

Challenges may include regulatory hurdles and the integration of advanced technologies in rehabilitation practices.

What are the emerging trends in the US Cardiac Rehabilitation Devices Market?

Emerging trends include increased digital health technologies and home-based rehabilitation solutions.

Which segment of the market is likely to witness the highest growth rate?

The Treadmill segment is expected to witness the highest growth rate, increasing to 230.0 million USD by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions